A recent study compares stereotactic ablative body radiotherapy (SABR) and microwave ablation for treating early-stage hepatocellular carcinoma. The findings contribute to understanding treatment efficacy in this patient population.
stereotactic ablative body radiotherapy versus microwave ablation for the treatment of early stage hepatocellular carcinoma
Original title: “Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation for the Treatment of Early-Stage Hepatocellular Carcinoma.”